CDC73, cell division cycle 73, 79577

N. diseases: 144; N. variants: 31
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 GeneticVariation disease BEFREE Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family. 28774260 2017
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 GeneticVariation disease BEFREE Pathogenic germline CDC73 variants were identified in 11 of the 89 referred pHPT patients (12.4%), with (suspected) hyperparathyroidism-jaw tumor (HPT-JT) syndrome (n = 3), familial isolated pHPT (n = 5), apparently sporadic parathyroid carcinoma (n = 2), and apparently sporadic parathyroid adenoma (n = 1). 29040582 2017
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 GeneticVariation disease BEFREE Moreover, CDC73 germline mutations occur in 20%-40% of patients with sporadic PC and may reveal unrecognized HPT-JT. 28881068 2017
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 GeneticVariation disease BEFREE Most pathogenic CDC73 missense mutations associated with the HPT-JT syndrome are located in the region encoding CDC73-NTD. 29142233 2017
CUI: C0687150
Disease: Parathyroid Gland Adenocarcinoma
Parathyroid Gland Adenocarcinoma
0.800 Biomarker disease BEFREE Loss of parafibromin immunostaining has been shown in most PC. 27001435 2016
CUI: C0687150
Disease: Parathyroid Gland Adenocarcinoma
Parathyroid Gland Adenocarcinoma
0.800 GeneticVariation disease BEFREE This is the first case documenting a germline 70 G>T HRPT2/CDC73 gene mutation in a pediatric parathyroid carcinoma. 27544721 2016
CUI: C0687150
Disease: Parathyroid Gland Adenocarcinoma
Parathyroid Gland Adenocarcinoma
0.800 Biomarker disease BEFREE A case of pediatric parathyroid carcinoma associated with haploinsufficiency of CDC73 is discussed. 26650250 2016
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 Biomarker disease BEFREE Parafibromin is a protein encoded by hyperparathyroidism 2 (HRPT2) and its downregulated expression is involved in the pathogenesis of parathyroid, breast, gastric, colorectal, lung, head and neck cancers. 26409451 2016
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 GeneticVariation disease BEFREE It also highlights the fact that HPT-JT should be considered and CDC73 mutation analysis should be performed in cases of early-onset PHPT associated with ossifying fibromas of the jaw. 26995009 2016
CUI: C0687150
Disease: Parathyroid Gland Adenocarcinoma
Parathyroid Gland Adenocarcinoma
0.800 Biomarker disease BEFREE The importance of CDC73 in PC is reinforced with a remarkable preferential amplification of the mutant CDC73 allele. 25387265 2015
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 GeneticVariation disease BEFREE The present case highlights that HPT-JT should be considered and CDC73 mutation analysis should be performed, especially in cases of early-onset PHPT, recurrent PHPT, PHPT with polyglandular parathyroid involvement, and PHPT presenting with severe hypercalcemia even if there is no positive family history. 25959515 2015
CUI: C0687150
Disease: Parathyroid Gland Adenocarcinoma
Parathyroid Gland Adenocarcinoma
0.800 GeneticVariation disease BEFREE A previously unreported intragenic deletion of exons 1 to 10 of CDC73 was detected in a three-generation family with FIHP, due to adenomas, atypical adenomas, and parathyroid carcinomas. 24823466 2014
CUI: C0687150
Disease: Parathyroid Gland Adenocarcinoma
Parathyroid Gland Adenocarcinoma
0.800 GeneticVariation disease BEFREE Our gene expression profiling experiments suggest that upregulated FGFR1 expression appears to be associated with parathyroid carcinoma in HPT-JT syndrome due to an HRPT2 splicing mutation. 24889687 2014
CUI: C0687150
Disease: Parathyroid Gland Adenocarcinoma
Parathyroid Gland Adenocarcinoma
0.800 Biomarker disease BEFREE The CDC73 gene, encoding parafibromin, has been identified as a tumour suppressor gene both in hyperparathyroidism-jaw tumour (HPT-JT) syndrome and in sporadic parathyroid carcinoma. 25113791 2014
CUI: C0687150
Disease: Parathyroid Gland Adenocarcinoma
Parathyroid Gland Adenocarcinoma
0.800 Biomarker disease BEFREE However, proponents have found immunohistochemistry for parafibromin useful to definitively confirm a pathological diagnosis of parathyroid carcinoma, predict a worse outcome in definite parathyroid carcinomas, triage formal genetic testing for HPT-JT syndrome, and predict the outcome of histologically atypical parathyroid adenomas. 24402736 2014
CUI: C0687150
Disease: Parathyroid Gland Adenocarcinoma
Parathyroid Gland Adenocarcinoma
0.800 CausalMutation disease CLINVAR Hyperparathyroidism-jaw tumor syndrome: Results of operative management. 25444225 2014
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 GeneticVariation disease BEFREE Hyperparathyroidism-jaw tumor syndrome (HPT-JT) is a rare, autosomal-dominant disease secondary to germline-inactivating mutations of the tumor suppressor gene HRPT2/CDC73. 25444225 2014
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 GeneticVariation disease BEFREE CDC73 mutations frequently underlie the hyperparathyroidism-jaw tumor syndrome, familial isolated hyperparathyroidism (FIHP), and parathyroid carcinoma. 24823466 2014
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 GeneticVariation disease BEFREE We report a novel mutation in the CDC73 gene that may underlie HPT-JT syndrome. 25113791 2014
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 Biomarker disease BEFREE Whether FIHP is a variant or an early stage of MEN1 syndrome or hyperparathyroidism-jaw tumor syndrome is yet to be established. 24121387 2014
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 GeneticVariation disease BEFREE Our gene expression profiling experiments suggest that upregulated FGFR1 expression appears to be associated with parathyroid carcinoma in HPT-JT syndrome due to an HRPT2 splicing mutation. 24889687 2014
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 GeneticVariation disease BEFREE To present the case of a hyperparathyroidism-jaw tumor (HPT-JT) patient with a novel nonsense mutation of the CDC73 gene. 23757631 2014
Hyperparathyroidism-Jaw Tumor Syndrome
0.800 Biomarker disease BEFREE However, proponents have found immunohistochemistry for parafibromin useful to definitively confirm a pathological diagnosis of parathyroid carcinoma, predict a worse outcome in definite parathyroid carcinomas, triage formal genetic testing for HPT-JT syndrome, and predict the outcome of histologically atypical parathyroid adenomas. 24402736 2014
CUI: C0687150
Disease: Parathyroid Gland Adenocarcinoma
Parathyroid Gland Adenocarcinoma
0.800 Biomarker disease BEFREE Previous studies, mostly based on familial cases of the disease, suggested potential roles for the tumour suppressor MEN1 and proto-oncogene RET in benign parathyroid tumourigenesis, while the tumour suppressor HRPT2 and proto-oncogene CCND1 may also act as drivers in parathyroid cancer. 23616356 2013
CUI: C0687150
Disease: Parathyroid Gland Adenocarcinoma
Parathyroid Gland Adenocarcinoma
0.800 GeneticVariation disease BEFREE In HPT-JT, mutations of CDC73/HRPT2 are associated with parathyroid carcinoma, but tumors of the kidneys and uterus are additional features. 23652676 2013